BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 27935022)

  • 1. Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.
    Skiba DS; Nosalski R; Mikolajczyk TP; Siedlinski M; Rios FJ; Montezano AC; Jawien J; Olszanecki R; Korbut R; Czesnikiewicz-Guzik M; Touyz RM; Guzik TJ
    Br J Pharmacol; 2017 Nov; 174(22):4055-4069. PubMed ID: 27935022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E
    Petri MH; Laguna-Fernandez A; Arnardottir H; Wheelock CE; Perretti M; Hansson GK; Bäck M
    Br J Pharmacol; 2017 Nov; 174(22):4043-4054. PubMed ID: 28071789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mas receptor activation attenuates allergic airway inflammation via inhibiting JNK/CCL2-induced macrophage recruitment.
    Hong L; Wang Q; Chen M; Shi J; Guo Y; Liu S; Pan R; Yuan X; Jiang S
    Biomed Pharmacother; 2021 May; 137():111365. PubMed ID: 33588264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
    Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
    Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Role of C3aR (C3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice.
    Wei LL; Ma N; Wu KY; Wang JX; Diao TY; Zhao SJ; Bai L; Liu E; Li ZF; Zhou W; Chen D; Li K
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2070-2083. PubMed ID: 32762445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.
    Rinne P; Guillamat-Prats R; Rami M; Bindila L; Ring L; Lyytikäinen LP; Raitoharju E; Oksala N; Lehtimäki T; Weber C; van der Vorst EPC; Steffens S
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2562-2575. PubMed ID: 30354245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.
    Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
    Vascul Pharmacol; 2017 Sep; 96-98():19-25. PubMed ID: 28347868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AVE0991, a nonpeptide angiotensin-(1-7) mimic, inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E knockout mice.
    Ma H; Wang YL; Hei NH; Li JL; Cao XR; Dong B; Yan WJ
    J Mol Med (Berl); 2020 Apr; 98(4):541-551. PubMed ID: 32060588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perivascular adipose tissue inflammation in vascular disease.
    Nosalski R; Guzik TJ
    Br J Pharmacol; 2017 Oct; 174(20):3496-3513. PubMed ID: 28063251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis.
    Stachowicz A; Wiśniewska A; Kuś K; Białas M; Łomnicka M; Totoń-Żurańska J; Kiepura A; Stachyra K; Suski M; Bujak-Giżycka B; Jawień J; Olszanecki R
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice.
    Yang G; Istas G; Höges S; Yakoub M; Hendgen-Cotta U; Rassaf T; Rodriguez-Mateos A; Hering L; Grandoch M; Mergia E; Rump LC; Stegbauer J
    Pflugers Arch; 2018 Apr; 470(4):661-667. PubMed ID: 29352340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
    Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.
    Erbel C; Akhavanpoor M; Okuyucu D; Wangler S; Dietz A; Zhao L; Stellos K; Little KM; Lasitschka F; Doesch A; Hakimi M; Dengler TJ; Giese T; Blessing E; Katus HA; Gleissner CA
    J Immunol; 2014 Nov; 193(9):4344-55. PubMed ID: 25261478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of angiotensin-(1-7) Mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice.
    Suski M; Olszanecki R; Stachowicz A; Madej J; Bujak-Giżycka B; Okoń K; Korbut R
    Biochim Biophys Acta; 2013 Dec; 1834(12):2463-9. PubMed ID: 23988828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
    Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice.
    Jawien J; Toton-Zuranska J; Gajda M; Niepsuj A; Gebska A; Kus K; Suski M; Pyka-Fosciak G; Nowak B; Guzik TJ; Marcinkiewicz J; Olszanecki R; Korbut R
    J Physiol Pharmacol; 2012 Feb; 63(1):77-85. PubMed ID: 22460464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-restricted endothelin-1 overexpression in type 1 diabetes worsens atherosclerosis and immune cell infiltration via NOX1.
    Ouerd S; Idris-Khodja N; Trindade M; Ferreira NS; Berillo O; Coelho SC; Neves MF; Jandeleit-Dahm KA; Paradis P; Schiffrin EL
    Cardiovasc Res; 2021 Mar; 117(4):1144-1153. PubMed ID: 32533834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells.
    Yang JM; Dong M; Meng X; Zhao YX; Yang XY; Liu XL; Hao PP; Li JJ; Wang XP; Zhang K; Gao F; Zhao XQ; Zhang MX; Zhang Y; Zhang C
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1978-85. PubMed ID: 23723368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.